Skip to main content
Log in

Septic Shock: Phenotypes and Outcomes

  • Original Research
  • Published:
Advances in Therapy Aims and scope Submit manuscript

Abstract

Introduction

Sepsis is a heterogeneous syndrome that results in life-threatening organ dysfunction. Our goal was to determine the relevant variables and patient phenotypes to use in predicting sepsis outcomes.

Methods

We performed an ancillary study concerning 119 patients with septic shock at intensive care unit (ICU) admittance (T0). We defined clinical worsening as having an increased sequential organ failure assessment (SOFA) score of ≥ 1, 48 h after admission (ΔSOFA ≥ 1). We performed univariate and multivariate analyses based on the 28-day mortality rate and ΔSOFA ≥ 1 and determined three patient phenotypes: safe, intermediate and unsafe. The persistence of the intermediate and unsafe phenotypes after T0 was defined as a poor outcome.

Results

At T0, the multivariate analysis showed two variables associated with 28-day mortality rate: norepinephrine dose and serum lactate concentration. Regarding ΔSOFA ≥ 1, we identified three variables at T0: norepinephrine dose, lactate concentration and venous-to-arterial carbon dioxide difference (P(v-a)CO2). At T0, the three phenotypes (safe, intermediate and unsafe) were found in 28 (24%), 70 (59%) and 21 (18%) patients, respectively. We thus suggested using an algorithm featuring norepinephrine dose, lactate concentration and P(v-a)CO2 to predict patient outcomes and obtained an area under the curve (AUC) of 74% (63–85%).

Conclusion

Our findings highlight the fact that identifying relevant variables and phenotypes may help physicians predict patient outcomes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):801–10.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Seymour CW, Liu VX, Iwashyna TJ, et al. Assessment of clinical criteria for sepsis: for the third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):762–74.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Fleischmann C, Scherag A, Adhikari NKJ, et al. Assessment of global incidence and mortality of hospital-treated sepsis. Current estimates and limitations. Am J Respir Crit Care Med. 2015;193(3):259–72.

  4. Gaieski D, Edwards J, Kallan M, Carr B. Benchmarking the incidence and mortality of severe sepsis in the United States. Crit Care Med. 2013;41(5):1167–74.

    Article  PubMed  Google Scholar 

  5. Vincent JL, Sakr Y, Sprung CL, et al. Sepsis in European intensive care units: results of the SOAP study. Crit Care Med. 2006;34(2):344–53.

  6. Cecconi M, De Backer D, Antonelli M, et al. Consensus on circulatory shock and hemodynamic monitoring. Task force of the European Society of Intensive Care Medicine. Intensive Care Med. 2014;40(12):1795–815.

  7. Evans L, Rhodes A, Alhazzani W, et al. Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock 2021. Crit Care Med. 2021;49(11):e1063–143.

    Article  PubMed  Google Scholar 

  8. Seymour CW, Rosengart MR. Septic shock: advances in diagnosis and treatment. JAMA. 2015;314(7):708–17.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Huang ACC, Lee TYT, Ko MC, et al. Fluid balance correlates with clinical course of multiple organ dysfunction syndrome and mortality in patients with septic shock. PLoS One. 2019;14(12):e0225423.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. ARISE Investigators, ANZICS Clinical Trials Group, Peake SL, et al. Goal-directed resuscitation for patients with early septic shock. N Engl J Med. 2014;371(16):1496–506.

  11. ProCESS Investigators, Yealy DM, Kellum JA, et al. A randomized trial of protocol-based care for early septic shock. N Engl J Med. 2014;370(18):1683–93.

  12. Mouncey PR, Osborn TM, Power GS, et al. Trial of early, goal-directed resuscitation for septic shock. N Engl J Med. 2015;372(14):1301–11.

    Article  CAS  PubMed  Google Scholar 

  13. Textoris J, Fouché L, Wiramus S, et al. High central venous oxygen saturation in the latter stages of septic shock is associated with increased mortality. Crit Care. 2011;15(4):R176.

    Article  PubMed  PubMed Central  Google Scholar 

  14. De Backer D, Orbegozo Cortes D, Donadello K, Vincent JL. Pathophysiology of microcirculatory dysfunction and the pathogenesis of septic shock. Virulence. 2014;5(1):73–9.

    Article  PubMed  Google Scholar 

  15. Pope JV, Jones AE, Gaieski DF, et al. Multicenter study of central venous oxygen saturation (ScvO(2)) as a predictor of mortality in patients with sepsis. Ann Emerg Med. 2010;55(1):40-46.e1.

    Article  PubMed  Google Scholar 

  16. Levy B. Lactate and shock state: the metabolic view. Curr Opin Crit Care. 2006;12(4):315–21.

    Article  PubMed  Google Scholar 

  17. Levraut J, Ciebiera JP, Jambou P, Ichai C, Labib Y, Grimaud D. Effect of continuous venovenous hemofiltration with dialysis on lactate clearance in critically ill patients. Crit Care Med. 1997;25(1):58–62.

    Article  CAS  PubMed  Google Scholar 

  18. van Genderen ME, Klijn E, Lima A, et al. Microvascular perfusion as a target for fluid resuscitation in experimental circulatory shock. Crit Care Med. 2014;42(2):e96-105.

    Article  PubMed  Google Scholar 

  19. Bakker J, de Backer D, Hernandez G. Lactate-guided resuscitation saves lives: we are not sure. Intensive Care Med. 2016;42(3):472–4.

    Article  PubMed  Google Scholar 

  20. Ding XF, Yang ZY, Xu ZT, et al. Early goal-directed and lactate-guided therapy in adult patients with severe sepsis and septic shock: a meta-analysis of randomized controlled trials. J Transl Med. 2018;16(1):331.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Bakker J, Postelnicu R, Mukherjee V. Lactate: where are we now? Crit Care Clin. 2020;36(1):115–24.

    Article  PubMed  Google Scholar 

  22. Ronflé R, Lefebvre L, Duclos G, et al. Venous-to-arterial carbon dioxide partial pressure difference: predictor of septic patient prognosis depending on central venous oxygen saturation. Shock. 2020;53(6):710–6.

    Article  PubMed  Google Scholar 

  23. Mallat J, Pepy F, Lemyze M, et al. Central venous-to-arterial carbon dioxide partial pressure difference in early resuscitation from septic shock: a prospective observational study. Eur J Anaesthesiol. 2014;31(7):371–80.

    Article  PubMed  Google Scholar 

  24. Ospina-Tascón GA, Bautista-Rincón DF, Umaña M, et al. Persistently high venous-to-arterial carbon dioxide differences during early resuscitation are associated with poor outcomes in septic shock. Crit Care. 2013;17(6):R294.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Gårdlund B, Dmitrieva NO, Pieper CF, Finfer S, Marshall JC, Taylor TB. Six subphenotypes in septic shock: latent class analysis of the PROWESS Shock study. J Crit Care. 2018;47:70–9.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Kim WY, Jung JW, Choi JC, Shin JW, Kim JY. Subphenotypes in patients with septic shock receiving vitamin C, hydrocortisone, and thiamine: a retrospective cohort analysis. Nutrients. 2019;11(12):2976.

    Article  PubMed Central  Google Scholar 

  27. Seymour CW, Kennedy JN, Wang S, et al. Derivation, validation, and potential treatment implications of novel clinical phenotypes for sepsis. JAMA. 2019;321(20):2003–17.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. László I, Trásy D, Molnár Z, Fazakas J. Sepsis: from pathophysiology to individualized patient care. J Immunol Res. 2015;2015:510436.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Toulouse E, Masseguin C, Lafont B, et al. French legal approach to clinical research. Anaesth Crit Care Pain Med. 2018;37(6):607–14.

  30. Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):801–10.

    CAS  PubMed  PubMed Central  Google Scholar 

  31. Leone M, Constantin JM, Dahyot-Fizelier C, et al. French intensive care unit organisation. Anaesth Crit Care Pain Med. 2018;37(6):625–7.

    Article  PubMed  Google Scholar 

  32. Gall JRL, Lemeshow S, Saulnier F. A new simplified acute physiology score (SAPS II) based on a European/North American multicenter study. JAMA. 1993;270(24):2957–63.

    Article  PubMed  Google Scholar 

  33. Vincent JL, Moreno R, Takala J, et al. The SOFA (sepsis-related organ failure assessment) score to describe organ dysfunction/failure: on behalf of the working group on sepsis-related problems of the European Society of Intensive Care Medicine (see contributors to the project in the appendix). Intensive Care Med. 1996;22(7):707–10.

    Article  CAS  PubMed  Google Scholar 

  34. Martin C, Medam S, Antonini F, et al. Norepinephrine: not too much, too long. Shock. 2015;44(4):305–9.

    Article  CAS  PubMed  Google Scholar 

  35. Gu WJ, Zhang Z, Bakker J. Early lactate clearance-guided therapy in patients with sepsis: a meta-analysis with trial sequential analysis of randomized controlled trials. Intensive Care Med. 2015;41(10):1862–3.

    Article  PubMed  Google Scholar 

  36. Guarracino F, Bertini P, Pinsky MR. Cardiovascular determinants of resuscitation from sepsis and septic shock. Crit Care. 2019;23(1):118.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Lamontagne F, Day AG, Meade MO, et al. Pooled analysis of higher versus lower blood pressure targets for vasopressor therapy septic and vasodilatory shock. Intensive Care Med. 2018;44(1):12–21.

    Article  PubMed  Google Scholar 

  38. Ip EH, Zhang Q, Schwartz R, et al. Multi-profile hidden Markov model for mood, dietary intake, and physical activity in an intervention study of childhood obesity. Stat Med. 2013;32(19):3314–31.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Ip EH, Zhang Q, Rejeski WJ, Harris TB, Kritchevsky S. Partially ordered mixed hidden Markov model for the disablement process of older adults. J Am Stat Assoc. 2013;108(502):370–80.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Rabiner LR. A tutorial on hidden Markov models and selected applications in speech recognition. Proc IEEE. 1989;77(2):257–86.

    Article  Google Scholar 

  41. Rejeski WJ, Ip EH, Bertoni AG, et al. Lifestyle change and mobility in obese adults with type 2 diabetes. N Engl J Med. 2012;366(13):1209–17.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Avis NE, Levine B, Marshall SA, Ip EH. Longitudinal examination of symptom profiles among breast cancer survivors. J Pain Symptom Manage. 2017;53(4):703–10.

    Article  PubMed  Google Scholar 

  43. Ip EH, Saldana S, Arcury TA, Grzywacz JG, Trejo G, Quandt SA. Profiles of food security for US farmworker households and factors related to dynamic of change. Am J Public Health. 2015;105(10):e42-47.

    Article  PubMed  PubMed Central  Google Scholar 

  44. Asfar P, Teboul JL, Radermacher P. High versus low blood-pressure target in septic shock. N Engl J Med. 2014;371(3):283–4.

  45. Lamontagne F, Richards-Belle A, Thomas K, et al. Effect of reduced exposure to vasopressors on 90-Day mortality in older critically ill patients with vasodilatory hypotension: a randomized clinical trial. JAMA. 2020;323(10):938–49.

  46. Rhodes A, Evans LE, Alhazzani W, et al. Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med. 2017;43(3):304–77.

    Article  PubMed  Google Scholar 

  47. Andreis DT, Singer M. Catecholamines for inflammatory shock: a Jekyll-and-Hyde conundrum. Intensive Care Med. 2016;42(9):1387–97.

    Article  CAS  PubMed  Google Scholar 

  48. Casserly B, Phillips GS, Schorr C, et al. Lactate measurements in sepsis-induced tissue hypoperfusion: results from the Surviving Sepsis Campaign database. Crit Care Med. 2015;43(3):567–73.

    Article  CAS  PubMed  Google Scholar 

  49. Howell MD, Donnino M, Clardy P, Talmor D, Shapiro NI. Occult hypoperfusion and mortality in patients with suspected infection. Intensive Care Med. 2007;33(11):1892–9.

    Article  PubMed  Google Scholar 

  50. Ospina-Tascón GA, Umaña M, Bermúdez W, et al. Combination of arterial lactate levels and venous-arterial CO2 to arterial-venous O2 content difference ratio as markers of resuscitation in patients with septic shock. Intensive Care Med. 2015;41(5):796–805.

    Article  PubMed  PubMed Central  Google Scholar 

  51. Vallée F, Vallet B, Mathe O, et al. Central venous-to-arterial carbon dioxide difference: an additional target for goal-directed therapy in septic shock? Intensive Care Med. 2008;34(12):2218–25.

    Article  PubMed  Google Scholar 

  52. Gårdlund B, Dmitrieva NO, Pieper CF, Finfer S, Marshall JC, Taylor TB. Six subphenotypes in septic shock: latent class analysis of the PROWESS Shock study. J Crit Care. 2018;47:70–9.

    Article  PubMed  PubMed Central  Google Scholar 

  53. Vincent JL. How I treat septic shock. Intensive Care Med. 2018;44(12):2242–4.

    Article  CAS  PubMed  Google Scholar 

  54. Lang E, Neuschwander A, Favé G, et al. Clinical decision support for severe trauma patients: machine learning based definition of a bundle of care for hemorrhagic shock and traumatic brain injury. J Trauma Acute Care Surg. 2022;92(1):135–43.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

The authors are indebted to the nursing staff of the polyvalent intensive care units for providing the best care to their patients. We thank all the participants of the study.

Funding

No funding or sponsorship was received for this study or publication of this article.

Author Contributions

Alexandre Cereuil: Concept, design and drafting the manuscript. Romain Ronflé: Concept, design and drafting the manuscript. Aurélien Culver: Reviewing. Mohamed Boucekine: statistical analysis. Laurent Papazian: Reviewing. Laurent Lefebvre: Reviewing. Marc Leone: Concept, design and reviewing the manuscript.

Compliance with Ethics Guidelines

The initial study was approved by the ethics committee of Nice University Hospital, France (Agreement number 2016-A00533-48). The ancillary study was also approved by the ethics committee of the French Society of Anaesthesia, Critical Care and Perioperative Medicine (SFAR), (Agreement number IRB 00010254-2022-078) and their opinion covers multiple hospitals. The requirement for written informed consent was waived because of this study’s strict observational design, according to French law [29]. However, we obtained the patient’s or relatives’ consent to use these data.

Disclosures

All the authors have nothing to disclose.

Data Availability

The datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Romain Ronflé.

Rights and permissions

Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cereuil, A., Ronflé, R., Culver, A. et al. Septic Shock: Phenotypes and Outcomes. Adv Ther 39, 5058–5071 (2022). https://doi.org/10.1007/s12325-022-02280-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12325-022-02280-5

Keywords

Navigation